It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
Potentially inappropriate medications (PIMs) can lead to adverse outcomes. This study aimed to investigate the prevalence of PIMs in older Chinese outpatients with heart failure according to the 2019 Beers criteria and the factors associated with PIMs.
Methods
A cross-sectional retrospective study was conducted using electronic medical data during January 1, 2020 to December 31, 2020 from 9 tertiary medical institutions in Chengdu, China. Outpatients aged 65 and above who were diagnosed with heart failure were included. The 2019 Beers criteria were used to evaluate the PIM status of older outpatients, and binary logistic regression was used to identify potential risk factors for PIMs.
Results
There were 3626 prescriptions. The prevalence of PIMs among older outpatients with heart failure was 67.98% according to the 2019 Beers criteria. Diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), benzodiazepine receptor agonist hypnotics, rivaroxaban, and dabigatran were the top five PIMs. The risks of PIMs were associated with the number of drugs prescribed and comorbidities. PIMs were shown to be more common in patients with polypharmacy (5–9 medications, OR: 10.403, 95% CI: 8.258–13.104, p < 0.001; ≥10 medications, OR: 35.018, 95% CI: 10.545-116.293, p < 0.001), valvular heart disease (OR: 1.537, 95% CI: 1.109–2.131, p = 0.010), and insomnia (OR: 2.655, 95% CI: 1.809–3.898, p < 0.001). While, medicare reimbursement (OR: 0.678, 95% CI: 0.570–0.808, p < 0.001) and visits to the geriatric departments (department of cardiology, OR: 1.687, 95% CI: 1.214–2.344, p = 0.002) were protective factors.
Conclusions
The prevalence of PIMs use was high among older Chinese outpatients with heart failure, according to this study. Multidisciplinary teams should cooperate to reduce PIMs in older adults.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer